Literature DB >> 1907530

Cytokine production by peripheral blood mononuclear cells in IgA nephropathy.

K N Lai1, J C Leung, P K Li, S F Lui.   

Abstract

The regulation of cytokine production and T cell proliferation by other cytokines is mandatory in mediating inflammatory responses but the full understanding is far from complete. We have previously reported increased production of IL-2 and IL-2 receptors (IL-2R) in IgA nephropathy. The present study was undertaken to examine other cytokine production during T cell activation in IgA nephropathy. Peripheral blood mononuclear cells (PBMC) from 17 IgA nephritic patients and 14 controls were cultured with phytohaemagglutinin and phorbol myristate acetate for 48 h for maximal cytokine production. IL-2Rs and IL-4 receptors (IL-4Rs) expressed on cultured PBMC were studied by a radioimmunoassay using monoclonal antibodies against these receptors. Although the total cellular IL-2R expression and percentages of T helper and T suppressor cells did not differ between the patients and controls, there was a significant increase in activated T helper cells expressing IL-2R in patients with IgA nephropathy. The total cellular IL-4R expression was elevated in IgA nephritic patients (P less than 0.005). IL-2 production by PBMC was raised in IgA nephritic patients compared with controls (P less than 0.05) but no difference in IL-4 or IL-6 production was observed. The interferon-gamma production by PBMC was significantly increased in patients with IgA nephropathy (P less than 0.025). No correlation was observed between individual cytokine levels. Our data suggest there are selective increases in cytokine production in IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907530      PMCID: PMC1535756          DOI: 10.1111/j.1365-2249.1991.tb05712.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response.

Authors:  J M Le; J Vilcek
Journal:  Lab Invest       Date:  1989-12       Impact factor: 5.662

2.  Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors.

Authors:  M M Simon; U Hochgeschwender; U Brugger; S Landolfo
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

Authors:  F Lee; T Yokota; T Otsuka; P Meyerson; D Villaret; R Coffman; T Mosmann; D Rennick; N Roehm; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment.

Authors:  M Larché; J R Lamb; M A Ritter
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

5.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

6.  B cell growth-promoting activity of recombinant human interleukin 4.

Authors:  T Defrance; B Vanbervliet; J P Aubry; Y Takebe; N Arai; A Miyajima; T Yokota; F Lee; K Arai; J E de Vries
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

7.  Interleukin 2 regulates its own receptors.

Authors:  K A Smith; D A Cantrell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.

Authors:  K N Lai; J C Leung; F M Lai
Journal:  Clin Nephrol       Date:  1988-12       Impact factor: 0.975

9.  Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor.

Authors:  M Larche; J R Lamb; R E O'Hehir; N Imami-Shita; E D Zanders; D E Quint; R Moqbel; M A Ritter
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

10.  B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.

Authors:  M Lotz; F Jirik; P Kabouridis; C Tsoukas; T Hirano; T Kishimoto; D A Carson
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  14 in total

1.  T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Authors:  S R Chintalacharuvu; N U Nagy; N Sigmund; J G Nedrud; M E Amm; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis.

Authors:  G Rostoker; H Terzidis; M Petit-Phar; D Meillet; P Lang; J M Dubert; G Lagrue; B Weil
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

3.  Phenotypic characterization of cytokine expression in patients with IgA nephropathy.

Authors:  N Yano; M Endoh; Y Nomoto; H Sakai; K Fadden; A Rifai
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

4.  Altered synthesis of interferon-gamma and expression of interferon-gamma receptor by peripheral blood mononuclear cells from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis.

Authors:  N Yano; M Endoh; R Naka; F Takemura; Y Nomoto; H Sakai
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

5.  Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.

Authors:  J W De Fijter; M R Daha; W E Schroeijers; L A van Es; C Van Kooten
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 6.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred.

Authors:  V Scivittaro; L Gesualdo; E Ranieri; C Marfella; S A Schewn; S N Emancipator; F P Schena
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.

Authors:  J Hayashi; Y Kishihara; K Yamaji; E Yoshimura; M Ohmiya; Y Tani; H Ikematsu; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

9.  Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin.

Authors:  J C Leung; C K Lai; Y L Chui; R T Ho; C H Chan; K N Lai
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.

Authors:  Koshi Yamada; Noriyoshi Kobayashi; Tomomi Ikeda; Yusuke Suzuki; Toshinao Tsuge; Satoshi Horikoshi; Steven N Emancipator; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2010-06-15       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.